Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$19.61
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
CareDx Analyst Ratings and Price Targets | NASDAQ:CDNA | Benzinga
CareDx Inc has a consensus price target of $28.88 based on the ratings of 9 analysts. The high is $40 issued by Stephens & Co. on February 27, 2025. The low is $15 issued by Craig-Hallum on May 1, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Stephens & Co., and Wells Fargo on March 3, 2025, February 27, 2025, and January 15, 2025, respectively. With an average price target of $29.67 between HC Wainwright & Co., Stephens & Co., and Wells Fargo, there's an implied 51.28% upside for CareDx Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Stephens & Co.
Wells Fargo
BTIG
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for CareDx
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/03/2025 | Buy Now | 27.49% | HC Wainwright & Co. | Yi Chen60% | $26 → $25 | Maintains | Neutral | Get Alert |
| 02/27/2025 | Buy Now | 103.98% | Stephens & Co. | Mason Carrico40% | $40 → $40 | Reiterates | Overweight → Overweight | Get Alert |
| 01/15/2025 | Buy Now | 22.39% | Wells Fargo | Brandon Couillard71% | $28 → $24 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 01/14/2025 | Buy Now | 32.59% | HC Wainwright & Co. | Yi Chen60% | $26 → $26 | Reiterates | Neutral → Neutral | Get Alert |
| 11/05/2024 | Buy Now | 78.48% | BTIG | Sung Ji Nam46% | $40 → $35 | Maintains | Buy | Get Alert |
| 10/22/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen60% | — | Reiterates | → Neutral | Get Alert |
| 10/16/2024 | Buy Now | 78.48% | Goldman Sachs | Matthew Sykes66% | $26 → $35 | Maintains | Buy | Get Alert |
| 08/27/2024 | Buy Now | 42.78% | Wells Fargo | Brandon Couillard71% | → $28 | Initiates | → Underweight | Get Alert |
| 08/19/2024 | Buy Now | 103.98% | BTIG | Sung Ji Nam46% | → $40 | Upgrade | Neutral → Buy | Get Alert |
| 08/01/2024 | Buy Now | 32.59% | Goldman Sachs | Matthew Sykes66% | $16 → $26 | Maintains | Buy | Get Alert |
| 08/01/2024 | Buy Now | 63.18% | Craig-Hallum | Connor Chamberlain61% | $22 → $32 | Maintains | Buy | Get Alert |
| 08/01/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen60% | — | Reiterates | → Neutral | Get Alert |
| 07/17/2024 | Buy Now | -18.41% | Goldman Sachs | Matthew Sykes66% | $14 → $16 | Maintains | Buy | Get Alert |
| 05/31/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen60% | — | Reiterates | → Neutral | Get Alert |
| 05/17/2024 | Buy Now | 12.19% | Craig-Hallum | Connor Chamberlain61% | $15 → $22 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen60% | — | Reiterates | → Neutral | Get Alert |
| 05/13/2024 | Buy Now | — | Raymond James | Andrew Cooper54% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/13/2024 | Buy Now | -28.61% | Goldman Sachs | Matthew Sykes66% | $10 → $14 | Maintains | Buy | Get Alert |
| 05/13/2024 | Buy Now | -8.21% | Stephens & Co. | Mason Carrico40% | $15 → $18 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | -23.51% | Craig-Hallum | Connor Chamberlain61% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | -23.51% | Craig-Hallum | Alexander Nowak64% | $12 → $15 | Upgrade | Hold → Buy | Get Alert |
| 04/17/2024 | Buy Now | -23.51% | Stephens & Co. | Mason Carrico40% | $15 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 11/09/2023 | Buy Now | -49.01% | Stephens & Co. | Mason Carrico40% | → $10 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/26/2023 | Buy Now | -49.01% | Stephens & Co. | Mason Carrico40% | → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/15/2023 | Buy Now | -38.81% | Raymond James | Andrew Cooper54% | → $12 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/09/2023 | Buy Now | — | HC Wainwright & Co. | Yi Chen60% | — | Reiterates | → Neutral | Get Alert |
| 07/11/2023 | Buy Now | — | Raymond James | Andrew Cooper54% | — | Maintains | Market Perform | Get Alert |
| 05/11/2023 | Buy Now | — | BTIG | Sung Ji Nam46% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/07/2023 | Buy Now | -54.11% | Stephens & Co. | Mason Carrico40% | $19 → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/07/2023 | Buy Now | -33.71% | Goldman Sachs | Matthew Sykes66% | $25 → $13 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | -54.11% | Craig-Hallum | Alexander Nowak64% | $26 → $9 | Downgrade | Buy → Hold | Get Alert |
| 03/03/2023 | Buy Now | 22.39% | Raymond James | Andrew Cooper54% | → $24 | Downgrade | Strong Buy → Market Perform | Get Alert |
| 02/28/2023 | Buy Now | 27.49% | BTIG | Mark Massaro72% | $28 → $25 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | -3.11% | Stephens & Co. | Mason Carrico40% | → $19 | Reiterates | → Overweight | Get Alert |
| 02/28/2023 | Buy Now | 32.59% | Craig-Hallum | Alexander Nowak64% | $32 → $26 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 27.49% | Goldman Sachs | Matthew Sykes66% | $29 → $25 | Maintains | Buy | Get Alert |
| 02/16/2023 | Buy Now | -3.11% | Stephens & Co. | Mason Carrico40% | → $19 | Reiterates | → Overweight | Get Alert |
| 02/06/2023 | Buy Now | 47.88% | Goldman Sachs | Matthew Sykes66% | $40 → $29 | Maintains | Buy | Get Alert |
| 01/31/2023 | Buy Now | 22.39% | Raymond James | Andrew Cooper54% | $26 → $24 | Maintains | Strong Buy | Get Alert |
| 11/08/2022 | Buy Now | 32.59% | Raymond James | Andrew Cooper54% | $35 → $26 | Maintains | Strong Buy | Get Alert |
| 11/07/2022 | Buy Now | 42.78% | BTIG | Mark Massaro72% | $37 → $28 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | 103.98% | Goldman Sachs | Matthew Sykes66% | $45 → $40 | Maintains | Buy | Get Alert |
| 08/10/2022 | Buy Now | 78.48% | Raymond James | Andrew Cooper54% | $45 → $35 | Maintains | Strong Buy | Get Alert |
| 05/06/2022 | Buy Now | 129.47% | Raymond James | Andrew Cooper54% | $52 → $45 | Maintains | Strong Buy | Get Alert |
| 04/25/2022 | Buy Now | 154.97% | Stephens & Co. | Mason Carrico40% | → $50 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for CareDx (CDNA) stock?
The latest price target for CareDx (NASDAQ:CDNA) was reported by HC Wainwright & Co. on March 3, 2025. The analyst firm set a price target for $25.00 expecting CDNA to rise to within 12 months (a possible 27.49% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CareDx (CDNA)?
The latest analyst rating for CareDx (NASDAQ:CDNA) was provided by HC Wainwright & Co., and CareDx maintained their neutral rating.
When was the last upgrade for CareDx (CDNA)?
The last upgrade for CareDx Inc happened on January 15, 2025 when Wells Fargo raised their price target to $24. Wells Fargo previously had an underweight for CareDx Inc.
When was the last downgrade for CareDx (CDNA)?
The last downgrade for CareDx Inc happened on May 13, 2024 when Raymond James changed their price target from N/A to N/A for CareDx Inc.
When is the next analyst rating going to be posted or updated for CareDx (CDNA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareDx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareDx was filed on March 3, 2025 so you should expect the next rating to be made available sometime around March 3, 2026.
Is the Analyst Rating CareDx (CDNA) correct?
While ratings are subjective and will change, the latest CareDx (CDNA) rating was a maintained with a price target of $26.00 to $25.00. The current price CareDx (CDNA) is trading at is $19.61, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.